Sr. Director, Epidemiology
Johnson & Johnson Innovative Medicine
Dave Kern, PhD, MS is a Sr. Director of Epidemology at Janssen Research & Development. Dr. Kern heads the epidmiology teams supporting the Neuroscience therapeutic area and the Established Products group. Specific focuses include the disease areas of major depressive disorder, schizophrenia, ADHD, Alzheimer's disease and dementia, and multiple sclerosis.